Universal coronavirus vaccines: the time to start is now
Luca T. Giurgea, Alison Han, Matthew J. Memoli
Abstract
The continued explosive spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite aggressive public health measures has triggered an unprecedented international vaccine effort. However, correlates of protection, which can help guide intelligent vaccine design, are not known for SARS-CoV-2. Research on influenza immunity and vaccine development may provide valuable lessons for coronavirus efforts, especially considering similarities in rapid evolutionary potential. The apparent inevitability of future novel coronavirus outbreaks must prompt work on a universal coronavirus vaccine.
Topics & Concepts
CoronavirusCoronavirus disease 2019 (COVID-19)PandemicOutbreakVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe acute respiratory syndrome coronavirusPublic health2019-20 coronavirus outbreakImmunityMedicineImmunologyImmune systemInfectious disease (medical specialty)DiseaseNursingPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesInfluenza Virus Research Studies